Skip to main content

Find Clinical Trials

Home
Conditions
Tick-Borne Diseases

Clinical trial condition

Tick-Borne Diseases

Explore clinical trials studying Tick-Borne Diseases. Study availability and eligibility vary by location and protocol.

129 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Tick-Borne Diseases trial results

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy Dębica, Poland

Szpital Jana Pawla II Oddzial Neuroinfekcji Krakow, Poland

View Trial Details

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

NCT00161772

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Neuschwansteinstrasse 5 Augsburg, Germany

Marktplatz 3 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

View all 23 locations

View Trial Details

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

NCT00161967

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Upper Austria, Austria

Hauptstrasse 240 Kehl, Germany

Niepubliczny ZOZ Zamość, Poland

View Trial Details

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

NCT00163540

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: SGS Biopharma Research Unit Stuivenberg Antwerp, Belgium

View Trial Details

Completed

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

NCT01368341

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +20 more
Locations: Antibiotic Centre for Primary Care, University of Oslo Oslo, Norway

View Trial Details

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

NCT01106482

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Winkelhoferstr. 3 Ehingen, Germany

Fuggerplatz 1 Kaufering, Germany

Hauptstrasse 240 Kehl, Germany

Bismarckstr. 3 Ludwigsburg, Germany

View Trial Details

Completed

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

NCT00804219

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Institute of Specific Prophylaxis and Tropical Medicine Vienna, State of Vienna, Austria

View Trial Details

Completed

Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation

NCT01243008

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +6 more
Locations: Clinical Trials Center, University and University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease

NCT00000938

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +6 more
Locations: Mark Klempner Boston, Massachusetts, United States

View Trial Details

Completed

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease

NCT00001101

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +6 more
Locations: Mark Klempner Boston, Massachusetts, United States

View Trial Details